Cancer & Hematology Centers of Western Michigan (CHC)’s Haritha Reddy, MD, has recently been published by Taylor & Francis Online. The article titled “Emerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors” examines immune checkpoint inhibitors (ICIs)s’ effects on small cell lung cancer (SCLC) therapies. It discusses that when added to chemotherapy, ICIs may improve survival in patients with advanced disease, the first advance in systemic therapy in SCLC in over 30 years.” To read the complete article, click here.
Founded in 1979, CHC has grown to become the largest physician-owned oncology and hematology practice in Michigan. We deliver advanced care in a personal way, and our expertise and caring approach make us dedicated to the help, healing and hope for cancer patients and their families. To learn more about our services and our clinics, please visit chcwm.com.
Becky Downing, Social Media & Marketing Specialist